天新药业 (603235)
JiangXi Tianxin Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameJiangxi Tianxin Pharmaceutical Co., Ltd.
Listing Date2022-07-12
Issue Price36.88RMB
Registered Capital4377810k RMB
Legal RepresentativeYu Xiaobing
Registered AddressIndustrial Park, Leping City, Jingdezhen City, Jiangxi Province
IndustryChemical Products
Main BusinessResearch, production, and sales of monomer vitamin products.
Company ProfileJiangxi Tianxin Pharmaceutical Co., Ltd. is primarily engaged in the research, production, and sales of monomer vitamin products. Its product portfolio includes Vitamin B6, Vitamin B1, Biotin, Folic Acid, Vitamin D3, Ascorbyl Palmitate, Vitamin E Powder, and others. The company's products are not only well-sold domestically but also exported to regions and countries across Asia, Europe, North America, South America, Oceania, and Africa, receiving widespread recognition from customers and enjoying a high industry reputation. Furthermore, the company's main products, Vitamin B6 and Vitamin B1, hold a significant global market share.
The company possesses 21 invention patents and 2 utility model patents. Eight specific product specifications, such as 'DC-grade Vitamin B6,' '2,4,5-Triamino-6-hydroxypyrimidine Sulfate,' and 'High-purity Folic Acid,' have been approved under the 'Jiangxi Provincial Key New Product Plan Projects.' The 'Green Synthesis Technology for Vitamin B1' received the Jiangxi Provincial Science and Technology Progress Second Prize and the Jingdezhen City Science and Technology Award, while the 'Preparation Method for Vitamin B6' was awarded the Jingdezhen City Science and Technology Award.
Stock Details
1. Key Indicators
- Total Shares(W): 43778.00
- Circulating A-Shares(W): 14706.52
- Earnings Per Share(RMB): 1.0600
- Net Assets Per Share(RMB): 10.9307
- Operating Revenue(W RMB): 163094.53
- Total Profit(W RMB): 55164.51
- **Net Profit Attributable to Parent(W RMB) **: 46030.39
- Net Profit Growth Rate(%): -6.91
- Weighted Return on Equity(%): 9.7600
- Operating Cash Flow Per Share(RMB): 1.1210
- Undistributed Profit Per Share(RMB): 4.9952
- Capital Reserve Per Share(RMB): 4.5726
2. Main Business
The main business covers:
- Research, development, production and sales of monomer vitamin products.
3. Company Basic Information
- Company Name: Jiangxi Tianxin Pharmaceutical Co., Ltd.
- Listing Date: 2022-07-12
- Industry: Pharmaceuticals & Healthcare - Chemical Pharmaceuticals
- Address: Industrial Park, Leping City, Jingdezhen City, Jiangxi Province
- Website: https://www.txpharm.com/
- Company Profile: The company was established as a joint stock company through the overall transformation of Tianxin Co., Ltd. On November 20, 2017, Tianxin Co., Ltd. held a shareholders' meeting and agreed to the overall transformation into a joint stock company. On the same day, Tianxin Pharmaceutical held its founding meeting and first shareholders' meeting, reviewing and approving the overall transformation into a joint stock company through net asset conversion, and the plan for Tianxin Pharmaceutical's total share capital and net asset conversion. On November 20, 2017, Lixin issued the "Capital Verification Report" (Xin Hui Shi Bao Zi [2017] No. ZA16362), verifying that the company's registered capital had been fully paid. On November 23, 2017, the Jingdezhen Market and Supervision Administration issued the "Business License" (Unified Social Credit Code: 91360200767014627G) to the company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Tonghe Private Securities Investment Fund Management Co., Ltd. - Tonghe Macro Hedge Phase I Private Securities Investment Fund | Private Securities Investment Fund | 42.50 | 0.29 |
| 2 | ChinaAMC CSI 800 Index Enhanced Securities Investment Fund Class A | Fund | 0.34 | 0.00 |
5. Concept Sectors
- Vitamins
- High-Performance Stocks
- Below IPO Price
- New Private Placements
Remarks
- Data update date: 2025-09-30
- Data source: Public Market Information
